Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunologic impact of the intestine in metabolic disease
Daniel A. Winer, Shawn Winer, Helen J. Dranse, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 1, pp. 33-42
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Inflammatory mechanisms linking obesity and metabolic disease
Alan R. Saltiel, Jerrold M. Olefsky
Journal of Clinical Investigation (2017) Vol. 127, Iss. 1, pp. 1-4
Open Access | Times Cited: 1667
An Integrated View of Immunometabolism
Yun Sok Lee, Joshua Wollam, Jerrold M. Olefsky
Cell (2018) Vol. 172, Iss. 1-2, pp. 22-40
Open Access | Times Cited: 373
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease
Baban S. Thawkar, Ginpreet Kaur
Journal of Neuroimmunology (2018) Vol. 326, pp. 62-74
Closed Access | Times Cited: 205
Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
Helen Luck, Saad Khan, Justin H. Kim, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 164
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
Franck Mauvais‐Jarvis
Diabetes (2020) Vol. 69, Iss. 9, pp. 1857-1863
Open Access | Times Cited: 162
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Carine Beaupère, Alexandrine Liboz, Bruno Fève, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 623-623
Open Access | Times Cited: 156
Chronic inflammation and the hallmarks of aging
Jordan J. Baechle, Nan Chen, Priya Makhijani, et al.
Molecular Metabolism (2023) Vol. 74, pp. 101755-101755
Open Access | Times Cited: 144
Obesity II: Establishing causal links between chemical exposures and obesity
Jerrold J. Heindel, Sarah Howard, Keren Agay‐Shay, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 115015-115015
Open Access | Times Cited: 130
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome
Larissa Sbaglia Celiberto, Franziska A. Graef, Genelle R. Healey, et al.
Immunology (2018) Vol. 155, Iss. 1, pp. 36-52
Open Access | Times Cited: 145
Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives
Sidharth Mishra, Shaohua Wang, Ravinder Nagpal, et al.
Microorganisms (2019) Vol. 7, Iss. 3, pp. 67-67
Open Access | Times Cited: 117
Antidiabetic Effects of Gegen Qinlian Decoction via the Gut Microbiota are Attributable to Its Key Ingredient Berberine
Xizhan Xu, Zezheng Gao, Fuquan Yang, et al.
Genomics Proteomics & Bioinformatics (2020) Vol. 18, Iss. 6, pp. 721-736
Open Access | Times Cited: 110
The Role of Neuronal NLRP1 Inflammasome in Alzheimer’s Disease: Bringing Neurons into the Neuroinflammation Game
Jeremy Kean Yi Yap, Ben Pickard, Elaine Wan Ling Chan, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 11, pp. 7741-7753
Closed Access | Times Cited: 106
The metabolic role of vagal afferent innervation
T.M. Zaved Waise, Helen J. Dranse, Tony K.T. Lam
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 10, pp. 625-636
Closed Access | Times Cited: 103
Emerging concepts in intestinal immune control of obesity-related metabolic disease
Saad Khan, Helen Luck, Shawn Winer, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 99
Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases
Kazunari Sugita, Kenji Kabashima
Journal of Leukocyte Biology (2020) Vol. 107, Iss. 5, pp. 749-762
Closed Access | Times Cited: 83
Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction
Carlos González-Quilen, Esther Rodríguez‐Gallego, Raúl Beltrán‐Debón, et al.
Nutrients (2020) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 82
Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors
Melina Farshbafnadi, Sara Kamali Zonouzi, Mohammadmahdi Sabahi, et al.
Experimental Gerontology (2021) Vol. 154, pp. 111507-111507
Open Access | Times Cited: 81
High fat diet-induced obesity leads to depressive and anxiety-like behaviors in mice via AMPK/mTOR-mediated autophagy
Yong Li, Yujie Cheng, Yuan Zhou, et al.
Experimental Neurology (2021) Vol. 348, pp. 113949-113949
Closed Access | Times Cited: 74
Micronutrients impact the gut microbiota and blood glucose
Nicole G. Barra, Fernando F. Anhê, Joseph F. Cavallari, et al.
Journal of Endocrinology (2021) Vol. 250, Iss. 2, pp. R1-R21
Open Access | Times Cited: 63
Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases
Yan Wan, Jia Xia, Jinfeng Xu, et al.
Pharmacological Research (2021) Vol. 175, pp. 106002-106002
Closed Access | Times Cited: 56
Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development
Sylvia Riedel, Carmen Pheiffer, Rabia Johnson, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 44
Lab-on-chip technologies for exploring the gut–immune axis in metabolic disease
Alexandra Wheeler, Verena Stoeger, Róisı́n M. Owens
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1266-1292
Open Access | Times Cited: 8
Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
Yi‐Hsuan Lin, Helen Luck, Saad Khan, et al.
International Journal of Obesity (2019) Vol. 43, Iss. 12, pp. 2407-2421
Open Access | Times Cited: 62
Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
Thomas Grabinger, Jesus Francisco Glaus Garzon, Martin Hausmann, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 57
The intestinal immune system and gut barrier function in obesity and ageing
Sarah J. Shemtov, Rohini Emani, Olga Bielska, et al.
FEBS Journal (2022) Vol. 290, Iss. 17, pp. 4163-4186
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top